These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9550604)

  • 1. Hematological diseases and apoptosis.
    Tohyama K; Kawabata H; Anzai N; Hishita T; Dodo M; Yoshida Y
    Intern Med; 1998 Feb; 37(2):188-90. PubMed ID: 9550604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recombinant hematopoietic growth factors in the treatment of various hematologic diseases].
    Pawelski S
    Acta Haematol Pol; 1991; 22(1):186-93. PubMed ID: 1823962
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hematopoietic growth factors].
    Robak T
    Postepy Hig Med Dosw; 1991; 45(6):461-96. PubMed ID: 1726024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor: present use and future directions.
    Shadduck RK
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):38-42. PubMed ID: 1492233
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical use of hematopoietic growth factors.
    Löwenberg B; Dale DC; Sheridan WP
    Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
    [No Abstract]   [Full Text] [Related]  

  • 6. Hematopoietic defects and iPSC disease modeling: lessons learned.
    Kelley JM; Daley GQ
    Immunol Lett; 2013; 155(1-2):18-20. PubMed ID: 24076116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Hematological Toxicities Using Mathematical Modeling.
    Fornari C; O'Connor LO; Yates JWT; Cheung SYA; Jodrell DI; Mettetal JT; Collins TA
    Clin Pharmacol Ther; 2018 Oct; 104(4):644-654. PubMed ID: 29604045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotherapy in hematology: the next decade.
    Quesenberry PJ
    Rev Invest Clin; 1994 Apr; Suppl():8-15. PubMed ID: 7886315
    [No Abstract]   [Full Text] [Related]  

  • 10. Hematopoietic stem cells: an overview.
    Mosaad YM
    Transfus Apher Sci; 2014 Dec; 51(3):68-82. PubMed ID: 25457002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal approaches to understanding the impact of mutations on hematologic disease development.
    Nangalia J; Mitchell E; Green AR
    Blood; 2019 Mar; 133(13):1436-1445. PubMed ID: 30728143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemothelium, Clonal Hematopoiesis of Indeterminate Potential, and Atherosclerosis.
    Aviv A; Levy D
    Circulation; 2019 Jan; 139(1):7-9. PubMed ID: 30592656
    [No Abstract]   [Full Text] [Related]  

  • 13. Clones assemble! The clonal complexity of blood during ontogeny and disease.
    Ganuza M; Hall T; Obeng EA; McKinney-Freeman S
    Exp Hematol; 2020 Mar; 83():35-47. PubMed ID: 32006606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
    Möhle R; Kanz L
    Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guest editorial: Institute of Hematology and Blood Diseases Hospital in China.
    Ema H
    Int J Hematol; 2016 May; 103(5):486. PubMed ID: 26964778
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical importance of the results of cloning hematopoietic cells from patients with leukemias and hematopoietic dysplasias].
    Kulibaba TG; Tiranova SA; Patterson D; Kravtsova VM; Afanas'ev BV
    Ter Arkh; 1986; 58(9):40-3. PubMed ID: 3787489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of haemopoietic growth factors in blood disorders.
    Hann IM
    Arch Dis Child; 1994 Dec; 71(6):543-7. PubMed ID: 7726619
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent progress in gene transfer into hematopoietic stem cells.
    Lutzko C; Dubé ID; Stewart AK
    Crit Rev Oncol Hematol; 1999 Apr; 30(2):143-58. PubMed ID: 10439059
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene editing and its application for hematological diseases.
    Osborn MJ; Belanto JJ; Tolar J; Voytas DF
    Int J Hematol; 2016 Jul; 104(1):18-28. PubMed ID: 27233509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndromes].
    Raza A; Vadhan-Raj S; Chávez-Sánchez G
    Rev Invest Clin; 1997 May; 49 Suppl 1():15-21. PubMed ID: 9380984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.